PPARG and Alzheimer disease: In conclusion, we have demonstrated the therapeutic efficacy of PB in an AD-like murine model, which mechanisms might be related to inhibit IL-17-induced inflammation, block NF-κB pathway and diminish miR-155 expression in a PPARγ-dependent manner (Fig. 11).